CRISPR Reagents

CXCR3 Gene Knockout Kit (Human)

Knockout any human or mouse protein-coding gene with XDel technology.

Bulk Upload
Need a quote? Add to cart and download one instantly at checkout — to reference on a purchase order, submit for budget approval, or keep for your records. No need to contact sales.

ENSG00000186810
This gene encodes a G protein-coupled receptor with selectivity for three chemokines, termed CXCL9/Mig (monokine induced by interferon-g), CXCL10/IP10 (interferon-g-inducible 10 kDa protein) and CXCL11/I-TAC (interferon-inducible T cell a-chemoattractant). Binding of chemokines to this protein induces cellular responses that are involved in leukocyte traffic, most notably integrin activation, cytoskeletal changes and chemotactic migration. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One of the isoforms (CXCR3-B) shows high affinity binding to chemokine, CXCL4/PF4 (PMID:12782716). [provided by RefSeq, Jun 2011]
Molecular Function9
Biological Process23
Cellular Component5

Common questions about the CXCR3 knockout kit

How many guides does the CXCR3 knockout kit use?
The kit's XDel design targets CXCR3 with 3 guides, and the earliest cut is in exon 2 of its canonical transcript.
Which CXCR3 transcripts does the knockout cut?
The XDel guides cut 3 CXCR3 transcripts, including the canonical transcript ENST00000373693. They cut all 3 of its CCDS protein-coding transcripts.
Do the CXCR3 guides cut other genes?
No. Our design analysis predicts no off-target potential in any other gene for these guides.
Gene Knockout Kits Provide Superior Editing Efficiency in iPSC, Immortalized, and Primary Cells and Consistent Protein Depletion Using the XDel Design
XDel is a cutting-edge CRISPR knockout technology designed to remove the guesswork from gene editing. By leveraging an innovative guide RNA design strategy, XDel delivers highly efficient, consistent, and reproducible gene knockouts—empowering researchers to accelerate their discoveries with confidence.